IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
about
RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammationTattoo removal with ingenol mebutate.Silencing of ASC in Cutaneous Squamous Cell Carcinoma.Inflammasomes in Inflammation-Induced Cancer.Early and Late Onset Side Effects of Photodynamic Therapy.
P2860
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@ast
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@en
type
label
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@ast
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@en
prefLabel
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@ast
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@en
P2093
P2860
P50
P1433
P1476
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
@en
P2093
Carly J Pierce
Kresten Skak
Wayne A Schroder
P2860
P304
P356
10.1371/JOURNAL.PONE.0153975
P407
P577
2016-04-21T00:00:00Z